IN8bio Inc (INAB)
1.01
+0.01
(+1.19%)
USD |
NASDAQ |
May 07, 16:00
0.9801
-0.03
(-2.96%)
After-Hours: 17:03
IN8bio Cash from Investing (TTM): -0.60M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.60M |
| September 30, 2023 | -1.791M |
| June 30, 2023 | -3.478M |
| March 31, 2023 | -3.881M |
| December 31, 2022 | -3.705M |
| September 30, 2022 | -2.598M |
| Date | Value |
|---|---|
| June 30, 2022 | -0.987M |
| March 31, 2022 | -0.562M |
| December 31, 2021 | -0.309M |
| September 30, 2021 | -0.153M |
| June 30, 2021 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-3.881M
Minimum
Mar 2023
--
Maximum
Jun 2021
-1.642M
Average
-0.987M
Median
Jun 2022
Cash from Investing (TTM) Benchmarks
| Jaguar Health Inc | 0.00 |
| Aptevo Therapeutics Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | -0.019M |
| Palatin Technologies Inc | 9.293M |
| iBio Inc | 8.285M |